Characterization of HPV-16 E6/E7 transcription in CaSki cells by quantitative PCR

Mol Cell Probes. 1992 Dec;6(6):459-66. doi: 10.1016/0890-8508(92)90042-v.

Abstract

Human papillomavirus (HPV) is associated with specific benign and malignant lesions of the epithelial and mucosal surfaces. Of the sexually transmitted types, HPV type 16 (HPV-16) is the most commonly associated with carcinoma of the uterine cervix. Expression of the E6/E7 open reading frame of the viral genome is considered critical in the development of neoplasia. Using the CaSki cervical carcinoma cell line as a model system, we have adapted the polymerase chain reaction to quantify the transcripts expressed from this region. It was found that 97.1% of the total spliced transcript is E6*I, which putatively encodes the E7 oncoprotein, while E6*II comprises 2.9% of spliced product. The ratio of E6*I to E6*II expression may be an important parameter in evaluating the disease risk associated with HPV-16 infection.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Base Sequence
  • Carcinoma / microbiology*
  • Carcinoma / pathology
  • DNA Probes, HPV
  • Female
  • Gene Expression Regulation, Neoplastic
  • Gene Expression Regulation, Viral
  • Humans
  • Molecular Sequence Data
  • Oncogene Proteins, Viral / biosynthesis
  • Oncogene Proteins, Viral / genetics*
  • Papillomavirus E7 Proteins
  • Polymerase Chain Reaction*
  • RNA Splicing
  • RNA, Neoplasm / analysis*
  • RNA, Viral / analysis*
  • Repressor Proteins*
  • Transcription, Genetic*
  • Tumor Cells, Cultured / metabolism
  • Tumor Cells, Cultured / microbiology*
  • Uterine Cervical Neoplasms / microbiology*
  • Uterine Cervical Neoplasms / pathology

Substances

  • DNA Probes, HPV
  • E6 protein, Human papillomavirus type 16
  • Oncogene Proteins, Viral
  • Papillomavirus E7 Proteins
  • RNA, Neoplasm
  • RNA, Viral
  • Repressor Proteins
  • oncogene protein E7, Human papillomavirus type 16